Scrip Articles

Shareholders should be concerned about the Board coup playing out at Rakon

NZSA Disclaimer Many shareholders and investors will have observed the events at Rakon over the last week, starting with the company’s announcement and notice of meeting issued on August 4th. The announcement noted that the election of three independent directors would not be supported by major shareholder Brent Robinson, his related family interests (19.67%) nor…
Read more

Pacific Edge Limited – 2025 Annual Meeting Report

Annual Meeting Report, August 6th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Revenue $10.4m $13.9m $19.6m $23.9m $21.8m -9% Operating Expenses $24.7m $33.7m $53.1m $58.8m $54.6m -7% NPAT -$14.2m -$19.8m -$27.0m -$29.5m -$29.3m n/a EPS -$0.0195 -$0.024 -$0.033 -$0.036 -$0.037 n/a Accumulated losses $217m $246m $276m…
Read more

Asset Plus Limited – 2025 Annual Meeting Report

Annual Meeting Report, August 5th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Revenue $13.9m $11.9m $6.4m $5.3m $6.8m 28% NPAT $15.9m $2.9m -$14.0m -$5.3m -$5.7m n/a Fair value gain/loss $9.2m -$1.2m -$12.7m -$4.9m -$7.2m n/a EPS $0.044 $0.008 -$0.039 -$0.015 -$0.016 n/a PE Ratio 8 33…
Read more

AFT Pharmaceuticals Limited – 2025 Annual Meeting Report

Annual Meeting Report, August 2nd 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Revenue $113.1m $130.3m $156.6m $195.4m $208.0m 6% NPAT $7.9m $19.8m $10.6m $15.6m $11.4m -27% EPS $0.074 $0.19 $0.102 $0.149 $0.109 -27% Inventory Turnover 2.28 2.04 2.20 2.34 2.38 2% Gross Margin 43% 47% 47%…
Read more

Green Cross Health Limited – 2025 Annual Meeting Report

Annual Meeting Report, July 31st 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 (restated) 2023 2024 2025 Change Revenue $570.4m $478.1m $493.6m $503.9m $523.8m 4% NPAT $21.0m $33.8m $50.5m $15.5m $20.7m 33% Profit attributable to shareholders $16.8m $24.6m $45.2m $11.8m $16.0m 36% EPS $0.117 $0.171 $0.315 $0.082 $0.111 36% PE Ratio…
Read more

Serko Limited – 2025 Annual Meeting Report

Annual Meeting Report, July 26th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Revenue $16.9m $18.9m $48.0m $71.2m $90.5m 27% NPAT -$28.7m -$36.0m -$30.5m -$15.7m -20.8m n/a EPS -$0.266 -$0.30 -$0.25 -$0.13 -$0.17 n/a PE Ratio n/a n/a n/a n/a n/a Capitalisation $766m $438m $270m $377m $392m…
Read more

Rangatira Limited – 2025 Annual Meeting Report

Annual Meeting Report, August 28th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 (re-stated) 2024 2025 Change Capitalisation $221m $248m $296m $307m $319m 4% Revenue $123.8m $132.6m $108.3m $106.5m $145.1m 36% NPAT $11.7m $10.0m $26.2m $17.4m $99.5m 472% Attributable to Equity holders $9.9m $9.1m $20.4m $16.2m $99.3m 514% EPS $0.557…
Read more

PharmaZen Limited – 2025 Annual Meeting Report

Annual Meeting Report, July 15th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2020 2021 2022 2023 2024 Change Operating Revenue $21.5m $20.5m $24.6m $28.9m $30.2m 5% Cost of Sales $12.0m $14.0m $16.3m $19.2m $21.3m 11% NPAT $3.8m -$.8m $0.8m $5.5m -$7.7m n/a Gross Profit Margin 44% 31% 34% 33% 29% -12% Inventory…
Read more

General Capital Limited – 2025 Annual Meeting Report

Annual Meeting Report, July 25th 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Gross Profit $2.3m $4.5m $7.7m $8.2m $9.9m 21% Interest Income $3.5m $5.6m $10.6m $13.7m $18.2m 33% NPAT $0.08m $1.3m $2.3m $2.6m $2.8m 7% EPS1 $0.0005 $0.0063 $0.0062 $0.029 $0.031 5% PE Ratio 112 9…
Read more

Argosy Property Limited – 2025 Annual Meeting Report

Annual Meeting Report, July 22nd 2025 Click here for NZSA Assessment and Voting Intentions Metric 2021 2022 2023 2024 2025 Change Operating Revenue $133.5m $131.6m $144.5m $153.2m $155.7m 2% Revaluations Gains $157.6m $163.6m -$146.5m -$112.7m $72.7m n/a NPAT $241.7m $236.1m -$80.8m -$55.3m $125.9m n/a EPS1 $0.288 $0.279 -$0.095 -$0.065 $0.149 n/a PE Ratio 5 4…
Read more